NASDAQ:PRLD | Income Statement | Prelude Therapeutics Inc

Complete source-backed income-statement history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$5.7M$16.13M$21.16M-$15.45M-$13.92M-$0.14-$0.1498,388,59398,388,593
2026-03-31$4.58M$13.6M$18.76M-$14.18M-$10.39M-$0.13-$0.1382,519,98182,519,981
2025-12-31$5.64M$17.99M$22.99M-$17.35M-$16.46M-$0.20-$0.20918,139918,139
2025-09-30$6.5M$21.71M$26.92M-$20.42M-$19.73M-$0.26-$0.2676,132,33776,132,337
2025-06-30$0.00$25.78M$32.19M-$32.19M-$31.23M-$0.41-$0.4175,993,94175,993,941
2025-03-31$0.00$28.82M$34.61M-$34.61M-$32.09M-$0.42-$0.4275,986,28175,986,281
2024-12-31$4M$31.62M$37.83M-$33.83M-$28.73M-$0.38-$0.3820,93820,938
2024-09-30$3M$29.46M$37.38M-$34.38M-$32.27M-$0.43-$0.4375,855,94975,855,949
2024-06-30$29.51M$37.16M-$37.16M-$34.74M-$0.46-$0.4675,762,15275,762,152
2024-03-31$27.41M$34.34M-$34.34M-$31.43M-$0.42-$0.4275,735,95475,735,954
2023-12-31$30.33M$37.38M-$37.38M-$33.08M-$0.47-$0.473,078,2573,078,257
2023-09-30$26.26M$33.39M-$33.39M-$30.61M-$0.45-$0.4567,639,99367,639,993
2023-06-30$24.97M$32.4M-$32.4M-$30.43M-$0.54-$0.5456,240,49156,240,491
2023-03-31$21.83M$29.12M-$29.12M-$27.72M-$0.58-$0.5847,737,19047,737,190
2022-12-31$25.87M$33.39M-$33.39M-$28.64M-$0.60-$0.60105,877105,877
2022-09-30$22.89M$30.41M-$30.41M-$29.96M-$0.63-$0.6347,449,81147,449,811
2022-06-30$21.31M$29.46M-$29.46M-$27.37M-$0.58-$0.5847,276,68447,276,684
2022-03-31$22.82M$30.29M-$30.29M-$29.47M-$0.63-$0.6347,066,42747,066,427
2021-12-31$25.18M$33.01M-$33.01M-$32.84M-$0.71-$0.71208,714208,714
2021-09-30$22.72M$30.84M-$30.84M-$30.69M-$0.66-$0.6646,330,79446,330,794
2021-06-30$22.41M$27.92M-$27.92M-$26.87M-$0.58-$0.5846,057,11246,057,112
2021-03-31$16.47M$21.97M-$21.97M-$21.3M45,121,955
2020-12-31$14.57M$19.45M-$19.45M-$19.25M10,098,363
2020-09-30$15.29M$18.14M-$18.14M-$16.76M3,194,471
2020-06-30$9.78M$11.44M-$11.44M-$11.41M2,074,108
2020-03-31$8.54M$9.74M-$9.74M-$9.51M1,857,023
2019-12-31$8.85M$10.1M-$10.1M-$10.04M46,003
2019-09-30$5.49M$6.88M-$6.88M-$6.73M1,713,371
2019-06-30-$5.56M
2019-03-31-$5.24M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$12.14M$94.3M$116.71M-$104.57M$0.00-$99.5M-$1.29-$1.2976,956,19476,956,194
2024-12-31$7M$118M$146.71M-$139.71M$0.00-$127.17M-$1.68-$1.6875,805,84075,805,840
2023-12-31$103.39M$132.28M-$132.28M-$121.83M-$2.02-$2.0260,357,05260,357,052
2022-12-31$92.89M$123.54M-$123.54M-$115.44M-$2.44-$2.4447,371,58947,371,589
2021-12-31$86.78M$113.74M-$113.74M-$111.69M-$2.43-$2.4346,049,76346,049,763
2020-12-31$48.18M$58.76M-$58.76M-$56.93M12,478,463
2019-12-31$24.28M$28.11M-$28.11M-$27.57M1,668,549